Concepedia

Marcus Ruscetti

MR

Statistics

Publications

12

Citations

2.1K

H-Index

12

Active since

2012

Affiliations

University of California, Los Angeles(Current)

Memorial Sloan Kettering Cancer Center

Howard Hughes Medical Institute

Peking University

Los Angeles Medical Center

Marcus Ruscetti is an author at University of California, Los Angeles specializing in oncology, molecular oncology, and medicine.

ORCID

Publications per year

2012–2024

12

Publications

12

<i>Pten</i> Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells

David J. Mulholland, Naoko Kobayashi, Marcus Ruscetti et al. · Cancer Research · 2012 · 483 citations

, , +17

NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination

Marcus Ruscetti, Josef Leibold, Matthew J. Bott et al. · Science · 2018 · 433 citations · Full text

, , +17

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

Marcus Ruscetti, John P. Morris, Riccardo Mezzadra et al. · Cell · 2020 · 416 citations · Full text

, , +12

Tracking and Functional Characterization of Epithelial–Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis

Marcus Ruscetti, Bill Quach, Eman L. Dadashian et al. · Cancer Research · 2015 · 230 citations · Full text

, , +17

HDAC inhibition impedes epithelial–mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer

Marcus Ruscetti, Eman L. Dadashian, Weilong Guo et al. · Oncogene · 2015 · 147 citations

, , +16

1–5 of 12